DexCom (DXCM) News
NASDAQ: DXCMHealth CareMedical/Dental InstrumentsUSD
84.11-0.30 (-0.36%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
DXCM news summary
We found 4 recent headlines mentioning DexCom (DXCM): 1 in the past week and 3 in the past 30 days, most often from Nasdaq. For price context, DXCM is down 0.36% at $84.11. The most recent story, "S&P 500 Analyst Moves: DXCM", was published by Nasdaq on Oct 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest DexCom headlines
- S&P 500 Analyst Moves: DXCMThe latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, DexCom is now the #9 analyst pick, moving up by 19 spots. This rank is…Nasdaq
- DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes CareDexcom sees room to expand CGM adoption as low awareness, reimbursement hurdles and rising GLP-1 use create new opportunities in Type 2 diabetes.NasdaqDXCM, ABT, NVO, MMED
- Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart RingOura Inc. (NASDAQ: OURA) launched its roadshow on Sept. 21, 2026, targeting a Nasdaq debut under the ticker OURA during the week of Sept. 28. Offering 50 million shares priced between $40 and $44…NasdaqLLY, DXCM, GRMN
- Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?IDEXX pairs resilient diagnostics growth, margin gains and expanding innovation with a premium valuation that supports a hold-or-wait stance.NasdaqIDXX, DXCM, INGN